Natco Current Affairs, GK & News

India violated WTO norms: United States

The U.S. administration accused India of infringing WTO norms by allowing Hyderabad-based Natco Pharma to produce a generic version of cancer drug Nexavar. The administration has called India’s move an ‘egregious’ violation of WTO norms. For a quick recall, India for the first time India had introduced a law allowing Natco Pharma to produce and ..